Omalizumab may protect allergic patients against COVID-19: A systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Omalizumab may protect allergic patients against COVID-19: A systematic review

Published:2023-02 Issue:2 Volume:16 Page:100741
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Ghiglioni Daniele Giovanni,Cozzi Laura,Castagnoli Riccardo,Bruschi Gaia,Maffeis Laura,Marchisio Paola Giovanna,Marseglia Gian Luigi,Licari Amelia

Funder

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference71 articles.

1. Asthma and COVID-19 associations: focus on IgE-related immune pathology;Wang;Life (Basel),2022

2. Anti-IgE monoclonal antibodies as potential treatment in COVID-19;Farmani;Immunopharmacol Immunotoxicol,2021

3. Immunological aspects related to viral infections in severe asthma and the role of omalizumab;Menzella;Biomedicines,2021

4. Antiviral activities of type I interferons to SARS-CoV-2 infection;Mantlo;Antivir Res,2020

5. Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID-19 deaths;Bastard;Sci Immunol,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bronchial Asthma and COVID-19: Etiology, Pathological Triggers, and Therapeutic Considerations;Pathophysiology;2024-05-27

2. COVID-19 Clinical Features and Outcome in Italian Patients Treated with Biological Drugs Targeting Type 2 Inflammation;Life;2024-03-13

3. COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial;Open Forum Infectious Diseases;2024-02-23

4. COVID-19 and Its Impact on Common Diseases in the Allergy Clinics;The Journal of Allergy and Clinical Immunology: In Practice;2023-11

5. Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status;Dermatology and Therapy;2023-09-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3